About
Copy Link
Titles
Staff Affiliate - YNHH
Biography
Hello to whoever is reading! Here is a little about me. And especially for applicants, please feel free to reach out if you have any questions. I would be happy to help however I can.
Hometown: Birmingham, AL
College: University of Alabama, Birmingham
Medical School: University of Maryland School of Medicine
------------------------------------
Prior to medicine: I spent time teaching English in Dhaka, Bangladesh.
Outside interests: Music, hiking, writing, cooking, basketball.
Career plans: Preventive Cardiology
Why I chose YPC: The culture and mission of YPC stood out to me during my interview cycle. (P.s. After being here 3 months, I can say that the great impression has lasted :) )
My favorite things about New Haven: Nearby beaches, hiking spots, good food options.
Talk to me more about: Anything!
Outside of the hospital you can find me: At the beach; on a hike; or visiting friends in NYC.
Scholarly interests: Prevention; implementation science; non-communicable diseases; cardiovascular health; global health; South Asian health.
Little known fact about me: Lived a year in South Africa during medical school!
If I wasn’t a physician, I would be: Journalist, epidemiologist, or photographer.
My advice for applicants: It is very easy to get too much input and be overstimulated or get decision fatigue. Focus on the big picture and listen to your gut instinct, and take the advice of others with a grain of salt.
Last Updated on September 28, 2022.
Departments & Organizations
- All Institutions
- Hamburg House Affiliates
- Internal Medicine
Education & Training
- MD
- University of Maryland, School of Medicine (2021)
- BS
- University of Alabama at Birmingham, Dept of Biology (2014)
- BA
- University of Alabama at Birmingham, Dept of Philosophy (2014)
Board Certifications
Internal Medicine
- Certification Organization
- ABIM
- Original Certification Date
- 2025
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Amiya Ahmed's published research.
Publications Timeline
A big-picture view of Amiya Ahmed's research output by year.
Sheela Shenoi, MD, MPH, FIDSA
Anthony Moll, MBChB
Lauretta Grau, PhD
18Publications
23Citations
Publications
2026
Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF.
Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra M, Pitt B, Butler J, Zullo AR, Moore HJ, Vargas JD, Arundel C, Sánchez-Vallejo CA, Deedwania P, Sheriff HM, Zeng-Treitler Q, Wu WC, Ahmed A. Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF. Eur J Heart Fail 2026 PMID: 41797492, DOI: 10.1093/ejhf/xuag076.Peer-Reviewed Original ResearchRisk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings.
Raman VK, Vargas JD, Moore HJ, Wu WC, Patel SS, Zhang S, Morgan CJ, Lam PH, Heidenreich PA, Lu F, Ahmed AA, Fonarow GC, Ahmed A. Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings. Am J Med 2026 PMID: 41724615, DOI: 10.1016/j.amjmed.2026.01.035.Peer-Reviewed Original Research
2025
Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure.
Moore HJ, Wu WC, Heidenreich PA, Rossignol P, Patel SS, Lu F, Lam PH, Ahmed AA, Faselis C, Butler J, Palant CE, Pitt B, Weir MR, Deedwania P, Atkins D, Raman VK, Rangaswami J, Vargas JD, Zhang S, Morgan CJ, Sheriff HM, Zeng-Treitler Q, Fonarow GC, Ahmed A. Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure. Am J Med 2025, 138: 1528-1538.e5. PMID: 40419103, DOI: 10.1016/j.amjmed.2025.05.024.Peer-Reviewed Original Research‘And the stick to fight TB is TPT’: nurse-identified barriers and facilitators of tuberculosis preventive therapy implementation in rural South Africa
Grammatico M, Moll A, Ahmed A, Grau L, Nsele S, Makhunga P, Jones J, Shenoi S. ‘And the stick to fight TB is TPT’: nurse-identified barriers and facilitators of tuberculosis preventive therapy implementation in rural South Africa. BMJ Open Respiratory Research 2025, 12: e002663. PMID: 41005953, PMCID: PMC12506236, DOI: 10.1136/bmjresp-2024-002663.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsRural South AfricaTuberculosis preventive therapyPrimary care clinicsPatients' alcohol useNurses' beliefsNursing perspectiveSenior nursesHIV stigmaTask shiftingCare clinicsInsufficient trainingAlcohol useIndividual-level barriersSemistructured individual interviewsResource-limited settingsInterpersonal barriersNursesOrganisational barriersPill burdenIndividual interviewsYears experienceMultiple barriersClinical guidelinesSouth AfricaTherapy implementationOutcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.
Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami J, Bakris G, Butler J, Sheriff HM, Allman RM, Zeng-Treitler Q, Wu WC, Ahmed A. Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF. JACC Heart Fail 2025, 13: 467-479. PMID: 39918536, DOI: 10.1016/j.jchf.2024.11.007.Peer-Reviewed Original ResearchDigoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure.
Lam PH, Liu K, Ahmed AA, Butler J, Heidenreich PA, Anker MS, Faselis C, Deedwania P, Aronow WS, Kanonidis I, Masson R, Gill GS, Morgan CJ, Arundel C, Allman RM, Wu WC, Fonarow GC, Ahmed A. Digoxin Discontinuation in Patients With HFrEF on Beta-Blockers: Implication for Future 'Knock-Out Trials' in Heart Failure. Am J Med 2025, 138: 495-503.e1. PMID: 39424217, DOI: 10.1016/j.amjmed.2024.10.015.Peer-Reviewed Original ResearchOutcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF
Patel S, Raman VK, Faselis C, Fonarow GC, Lam PH, Ahmed AA, Heidenreich PA, Anker SD, Deedwania P, Morgan CJ, Zhang S, Moore H, Rangaswami J, Bakris G, Butler J, Sheriff HM, Allman RM, Zeng-Treitler Q, Wu WC, Ahmed A. Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF. JACC: Heart Failure 2025, 13 DOI: 10.1016/j.jchf.2024.11.007.Peer-Reviewed Original Research
2023
A pilot study: Application of paired ultrasound simulator training in obstetrics.
Kegel S, Elsamadicy E, Seger L, Ahmed AA, Makar E, Turan O, Turan S. A pilot study: Application of paired ultrasound simulator training in obstetrics. J Clin Ultrasound 2023, 51: 1155-1163. PMID: 37218334, DOI: 10.1002/jcu.23494.Peer-Reviewed Original ResearchRenin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
Patel S, Lam PH, Kanonidis EI, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A. Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease. Am J Med 2023, 136: 677-686. PMID: 37019372, DOI: 10.1016/j.amjmed.2023.03.017.Peer-Reviewed Original Research
2022
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C, Nations JA, Morgan CJ, Antevil J, Roseman JM, Zhang S, Fonarow GC, Sheriff HM, Trachiotis GD, Allman RM, Deedwania P, Zeng-Trietler Q, Taub DD, Ahmed AA, Howard G, Ahmed A. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended. JAMA Oncology 2022 PMID: 35900734, DOI: 10.1001/jamaoncol.2022.2952.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Get In Touch
Copy Link
Contacts
Email